Clinical Research Directory
Browse clinical research sites, groups, and studies.
Diabetes Discharge Transitional CGM Study (DDT-CGM)
Sponsor: Intermountain Health Care, Inc.
Summary
Intervention group will receive brief diabetic education, CGM education and use and have a CGM placed before discharge. They will also sign up for "Cloud" access of their CGM data. A medical assistant will review their CGM data daily to make sure they are using the CGM adequately. The principal investigator will review the CGM data and call the patient for a brief phone evaluation of their glucoses and their transition from the hospital to outpatient care. The will be called 4 times between discharge and day 15 by the principal investigator. Standard treatment group will receive a blinded CGM to be reviewed 30 days after discharge. Reduction in hospitalizations and ER visits within the first 30 days is the primary outcome. Time in range, hypoglycemia, hyperglycemia and patient satisfaction will also be evaluated 30 days after discharge.
Official title: Daibetes Discharge Transitional CGM Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2021-06-01
Completion Date
2024-12-01
Last Updated
2024-02-26
Healthy Volunteers
Yes
Conditions
Interventions
CGM device with diabetic education, CGM education and a follow up protocol.
Blind CGM placed and recorded for 14 days after discharge and data downloaded
Locations (1)
Logan Regional Hospital
Logan, Utah, United States